The Swedish National Programme for Quality Control of Secondary Prevention of Coronary Artery Disease - results after one year

European Journal of Preventive Cardiology

Volumn 11, Issue 1, 2004, Pages 18-24

  Stagmo, Martin ^a   Israelsson, bo ^a   Brandstrãm, Hans ^b   Hedbãck, bo ^a   Lingfors, Hans ^c   Nilsson, Peter ^d   Erhardt, Leif ^a  

^a University Hospital   (Sweden)

^b Grãbo Health Centre   (Sweden)

^c Box 1442   (Sweden)

^d NONE   (Sweden)

Author keywords

coronary artery disease; guidelines; quality control; secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; WARFARIN;

BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DIASTOLIC BLOOD PRESSURE; HEALTH PROGRAM; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; REGISTER; REVIEW; RISK FACTOR; RISK MANAGEMENT; SECONDARY PREVENTION; SWEDEN; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOLOGY; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; DIASTOLE; EFFICIENCY, ORGANIZATIONAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PATIENT DISCHARGE; PREVENTIVE HEALTH SERVICES; PROGRAM EVALUATION; QUALITY CONTROL; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; RISK MANAGEMENT; SWEDEN; SYSTOLE;

EID: 1642328868     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000116981.98984.6b     Document Type: Article

References (16)

1. Wood D, De Becker G, Faergeman O, Graham I, Mancia G, Pyörälä K, together with members of the Task Force. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Task Force of the European and other Societies for Coronary Prevention. Eur Heart J 1998; 19: 1434–1503.
2. Summary of the Second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993; 269: 3015–3023.
3. EUROASPIRE Study Group. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J 1997; 18: 1569–1582.
4. Bowker TJ, Clayton TC, McLennan NR, Hobson HL, Pyke SD, et al. A British Cardiac Society Survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart 1996; 75: 334–342.
5. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000 28; 160: 459–467.
6. EUROASPIRE study group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001; 22: 554–572.
7. Hibble A, Kanka D, Pencheon D, Poolesw F. Guidelines in general practice: the new Tower of Babel? BMJ 1998; 317: 862–863.
8. Bramlet DA, King H, Young L, Witt JR, Stoukides CA, Kaul AF. Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists. Am J Cardiol 1997; 80 (Suppl): 39H–44H.
9. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM. Secondary prevention in coronary heart disease: baseline survey of provision in general practices. BMJ 1998; 316: 1430–1434.
10. Gandhi MM, Lampe FC, Wood DA. Management of angina pectoris in general practice: a questionnaire survey of general practitioners. Br J Gen Pract 1995; 45: 11–13.
11. Erhardt L. The essence of effective treatment and compliance is simplicity. Am J Hypertens 1999; 12: 1S–6S.
12. Levknecht L, Schriefer J, Schriefer J, Maconis B. Combining case management, pathways and report cards for secondary cardiac prevention. J Quality Improvement 1997; 23: 162–174.
13. Campbell NC, Ritchie LD, Thain J, Deans HG, Rawles JM, Squair JL. Nurserun clinics in primary care increased secondary prevention in coronary artery disease. Heart 1998; 80: 447–452.
14. Secondary prevention in CAD. National Board of Health and Welfare 1992: 16, Stockholm, 1993.
15. Strandberg TE, Pitkanen A, Larjo P, Hirvonen P, Kohvakka A. Attitude changes of general practitioners towards lowering LDL cholesterol. J Cardiovasc Risk 1998; 5: 43–46.
16. Nilsson P, Brandstrom H, Lingfors E, Erhardt L, Hedbäck B, et al. Gender differences in secondary prevention of coronary heart disease: reasons to worry or not? Scand J Prim Health Care 2003; 21: 37–42.